Stocks are slipping again to start the week. Crude oil, gold, and silver are also lower, while Treasuries and the dollar are mostly flat.

Tech stocks are taking on water again to start the week, with worries about the “AI Trade” continuing to work their way through markets. Nvidia Corp. (NVDA) is set to report quarterly results on Tuesday after the market closes, and that could be a major catalyst for the next big move in tech.

Analysts expect the chipmaker to report $2.47 per share in earnings and $108.7 billion in sales. Colette Kress, the successor to Jensen Huang, will lead the earnings call as interim CEO. Nvidia stock is down 28% in the last month.

IPO (Red), SPCX (Blue), NVDA, (Black) 1-Mo. % Change

chart

Source: TradingView

The other big tech development this week is Anthropic PBC’s Initial Public Offering (IPO). The mega-deal is set to price on Wednesday, with the stock commencing trading on Thursday under the ticker symbol “ANT.”

Anthropic is planning to sell 825 million shares at a price of $70 to $78. Factoring in an additional private placement of shares, the firm could raise more than $90 billion. That would make this the largest IPO ever, eclipsing the $75 billion SpaceX (SPCX) deal in June. But it comes as many tech stocks have pulled back. SpaceX stock is down 14.9% in the last month, while the Renaissance IPO ETF (IPO) is off 10.7%.

Lastly, we haven’t had too many big “Merger Monday” deals to discuss. But Johnson & Johnson (JNJ) is reportedly buying the privately held biotechnology company Ollin Biosciences for $3.4 billion. The Financial Times reported the deal, which would bring Ollin’s experimental eye disease drug OLN324 into the fold. J&J also bought Firefly Bio for $1 billion this year, as well as Intra-Cellular Therapies for $14.6 billion in 2025.